Portal vein embolization prior to hepatectomy: Techniques, outcomes and novel therapeutic approaches

Matthew L. Hung, J. McWilliams
{"title":"Portal vein embolization prior to hepatectomy: Techniques, outcomes and novel therapeutic approaches","authors":"Matthew L. Hung, J. McWilliams","doi":"10.18528/GII180010","DOIUrl":null,"url":null,"abstract":"would not benefit from PVE. Although two-stage hepatectomy has extended surgical candidacy to patients with bilobar disease, 13 diffuse multifocal disease remains a contraindication to PVE. PVE is unnecessary in the case of complete lobar portal vein thrombosis, as flow is already diverted. 14 Other relative contraindications include Hepatectomy plays a pivotal role in the management of primary and secondary malignancies of the liver, and offers a curative option for the patient. Postoperative liver failure is a severe complication of liver resection, particularly for patients with underlying liver disease. Portal vein embolization (PVE) is a well-established preoperative technique that redirects blood flow to the anticipated remaining liver after resection in an effort to improve the functional hepatic reserve. PVE has improved the safety of hepatectomy and has extended surgical candidacy to patients who previously would have been ineligible for resection because of insufficient remnant liver volume. This article reviews the following aspects of PVE; indications, contra- indications, liver volumetry, approaches, embolization agents, recent outcomes data, and areas of active research including adjunctive therapies and temporary PVE.","PeriodicalId":32516,"journal":{"name":"Gastrointestinal Intervention","volume":"7 1","pages":"2-8"},"PeriodicalIF":0.0000,"publicationDate":"2018-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastrointestinal Intervention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18528/GII180010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

would not benefit from PVE. Although two-stage hepatectomy has extended surgical candidacy to patients with bilobar disease, 13 diffuse multifocal disease remains a contraindication to PVE. PVE is unnecessary in the case of complete lobar portal vein thrombosis, as flow is already diverted. 14 Other relative contraindications include Hepatectomy plays a pivotal role in the management of primary and secondary malignancies of the liver, and offers a curative option for the patient. Postoperative liver failure is a severe complication of liver resection, particularly for patients with underlying liver disease. Portal vein embolization (PVE) is a well-established preoperative technique that redirects blood flow to the anticipated remaining liver after resection in an effort to improve the functional hepatic reserve. PVE has improved the safety of hepatectomy and has extended surgical candidacy to patients who previously would have been ineligible for resection because of insufficient remnant liver volume. This article reviews the following aspects of PVE; indications, contra- indications, liver volumetry, approaches, embolization agents, recent outcomes data, and areas of active research including adjunctive therapies and temporary PVE.
肝切除术前门静脉栓塞:技术、结果和新的治疗方法
不会从PVE中受益。尽管两阶段肝切除术已将手术候选范围扩大到双叶疾病患者,但13弥漫性多灶性疾病仍然是PVE的禁忌症。在完全性大叶门静脉血栓形成的情况下,PVE是不必要的,因为血流已经被分流。14其他相关禁忌症包括肝切除术在原发性和继发性肝脏恶性肿瘤的治疗中起着关键作用,并为患者提供了治疗选择。术后肝功能衰竭是肝切除术的严重并发症,尤其是对有潜在肝病的患者。门静脉栓塞(PVE)是一种成熟的术前技术,它可以在切除后将血流重定向到预期的剩余肝脏,以提高肝脏的功能储备。PVE提高了肝切除术的安全性,并将手术候选范围扩大到以前因残余肝容量不足而不符合切除条件的患者。本文综述了PVE的以下几个方面;适应症、禁忌症、肝容量测定、方法、栓塞剂、最近的结果数据以及积极研究的领域,包括辅助治疗和临时PVE。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
24 weeks
期刊介绍: IJGII (pISSN 2636-0004, eISSN 2636-0012) was published four times a year on the last day of January, April, July, and October, which has effected from January 1 in 2019. This Journal was first published biannually on June and December, beginning in December 2012 under the title ‘Gastrointestinal Intervention’ (former pISSN 2213-1795, eISSN 2213-1809) and was changed to be published three times a year from 2016. Commencing with the January 2019 issue, the Journal was renamed ‘International Journal of Gastrointestinal Intervention’. As the official journal of the Society of Gastrointestinal Intervention (SGI), International Journal of Gastrointestinal Intervention (IJGII) delivers original, peer-reviewed articles for gastroenterologists, interventional radiologists, surgeons, gastrointestinal oncologists, nurses and technicians who need current and reliable information on the interventional treatment of gastrointestinal and hepatopancreaticobiliary diseases. Regular features also include ‘state-of-the-art’ review articles by leading authorities throughout the world. IJGII will become an international forum for the description and discussion of the various aspects of interventional radiology, endoscopy and minimally invasive surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信